Craft

Yifan Pharmaceutical

Stock Price

¥12

2024-10-29

Market Capitalization

¥14.4 B

2024-10-29

Revenue

¥5.1 B

FY, 2025

Yifan Pharmaceutical Summary

Company Summary

Overview
Yifan Pharmaceutical is a company that manufactures biochemicals. It offers compound huangdai tablets, oxytocin nasal sprays, and other products.
Type
Public
Status
Active
Website
http://www.xinfupharm.com
Cybersecurity rating
Sectors

Table of Contents

Yifan Pharmaceutical Financials

Summary Financials

Revenue (Q1, 2026)
¥1.2B
Gross profit (Q1, 2026)
¥561.8M
Net income (Q1, 2026)
¥95.7M
Cash (Q1, 2026)
¥751.2M
EBIT (Q1, 2026)
¥144.6M
Enterprise value
$16.0B

Footer menu